sq-11725 has been researched along with D-fructopyranose in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leira, R; Pascual, J; Rivas, MT | 1 |
Bilbao, A; Foncea, N; Garcia-Monco, JC; Gomez-Beldarrain, M; Ruiz de Velasco, I | 1 |
Artal-Roy, J; García-Gómara, MJ; Gracia-Naya, M; Huerta-Villanueva, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S | 1 |
Artal-Roy, J; García-Gomara, MJ; Gracia-Naya, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S | 1 |
2 trial(s) available for sq-11725 and D-fructopyranose
Article | Year |
---|---|
Testing the combination beta-blocker plus topiramate in refractory migraine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Propranolol; Topiramate; Treatment Outcome | 2007 |
Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anticonvulsants; Anxiety; Depression; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Quality of Life; Surveys and Questionnaires; Topiramate | 2007 |
2 other study(ies) available for sq-11725 and D-fructopyranose
Article | Year |
---|---|
[Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients].
Topics: Adrenergic beta-Antagonists; Adult; Female; Fructose; Humans; Male; Migraine Disorders; Nadolol; Topiramate | 2010 |
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine].
Topics: Adrenergic beta-Antagonists; Adult; Anticonvulsants; Female; Flunarizine; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Patient Dropouts; Patient Satisfaction; Prospective Studies; Risk Factors; Topiramate; Treatment Outcome; Young Adult | 2011 |